Lysosomes, cholesterol and atherosclerosis

Clinical Lipidology

Volumn 5, Issue 6, 2010, Pages 853-865

  Jerome, W Gray ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

atherosclerosis; cholesterol; lysosomes; macrophage; triglyceride

Indexed keywords

CHOLESTEROL; STEROL; TRIACYLGLYCEROL;

ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL FUNCTION; CELL MOTILITY; CHOLESTEROL METABOLISM; DISEASE COURSE; FOAM CELL; HUMAN; LIPID OXIDATION; LIPID STORAGE; LYSOSOME; LYSOSOME MEMBRANE; MACROPHAGE ACTIVATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 79952168243     PISSN: 17460875     EISSN: None     Source Type: Journal    
DOI: 10.2217/clp.10.70     Document Type: Review

References (111)

1. Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R: Concept of vulnerable/unstable plaque. Arterioscler. Thromb. Vasc. Biol. 30(7), 1282-1292 (2010).
2. Steinberg D: Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: part I. J. Lipid Res. 45(9), 1583-1593 (2004).
3. Jerome WG: Advanced atherosclerotic foam cell formation has features of an acquired lysosomal storage disorder Rej. Res. 9, 245-255 (2006). (Pubitemid 43856817)
4. Goldstein JL, Ho YK, Basu SK, Brown MS: Binding sites on macrophages that mediate uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl Acad. Sci. USA 76, 333-337 (1979). (Pubitemid 9110191)
5. Goldstein J, Debose-Boyd R, Brown M: Protein sensors for membrane sterols. Cell 124, 35-46 (2006).
6. Greaves D, Gordon S: The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges. J. Lipid Res. 50(Suppl.), S282-S286 (2009).
7. Woollard K, Geissmann F: Monocytes in atherosclerosis: subsets and functions. Nat. Rev. Cardiol. 7(2), 77-86 (2010).
8. Brown MS, Goldstein JL: Lipoprotein metabolism in the macrophage. Ann. Rev. Biochem. 52, 223-261 (1983).
9. Steinbrecher U, Lougheed M, Kwan W, Dirks M: Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation. J. Biol. Chem. 264, 15216-15223 (1989). (Pubitemid 19242882)
10. Buton X, Mamdouh Z, Ghosh R et al.: Unique cellular events occurring during the initial interaction of macrophages with matrix-retained or methylated aggregated LDL. J. Biol. Chem. 274, 32112-32121 (1999).
11. Steinberg D, Parthasarathy S, Carew T, Khoo J, Witztum J: Beyond cholesterol, modification of low-density lipoproteins that increase its atherogenicity. N. Engl. J. Med. 320, 915-924 (1989). (Pubitemid 19101597)
12. Hoff H, Hoppe G: Structure of cholesterol-containing particles accumulating in atherosclerotic lesions and the mechanisms of their derivation. Curr. Opin. Lipidol. 6(5), 317-325 (1995).
13. Williams K, Tabas I: The response-to-retention hypothesis of atherogenesis reinforced. Curr. Opin. Lipidol. 9, 471-474 (1998). (Pubitemid 28495557)
14. Rothblat GH, Rosen JM, Insull W, Yau AO, Small DM: Production of cholesteryl ester-rich anisotropic inclusions by mammalian cells in culture. Exp. Mol. Pathol. 26, 318-324 (1977). (Pubitemid 8094189)
15. Kruth H: Sequestration of aggregated low-density lipoproteins by macrophages. Curr. Opin. Lipidol. 13, 483-488 (2002). (Pubitemid 35231927)
16. Tabas I: Nonoxidative modifications of lipoproteins in atherogenesis. Ann. Rev. Nutr. 19, 123-139 (1999). (Pubitemid 29380599)
17. Tabas I: Macrophage death and defective inflammation resolution in atherosclerosis. Nat. Rev. Immunol. 10(1), 36-46 (2010).
18. Wolfbauer G, Glick JM, Minor LK, Rothblat GH: Development of the smooth muscle foam cell: uptake of macrophage lipid inclusions. Proc. Natl Acad. Sci. USA 83(20), 7760-7764 (1986). (Pubitemid 17183924)
19. Tabas I, Myers J, Innerarity T, Xu X, Arnold J, Maxfield F: The influence of particle size and multiple apoprotein E-receptor interactions on the endocytic targeting of b-VLDL in mouse. J. Cell Biol. 115, 1547-1560 (1991). (Pubitemid 21909995)
20. Kruth H, Chang J, Ifrim I, Zhang W-Y: Characterization of patocytosis: endocytosis into macrophage surface-connected compartments. Eur. J. Cell Biol. 78, 91-99 (1999). (Pubitemid 29112470)
21. Soccio R, Breslow J: Intracellular cholesterol transport. Arterioscl. Thromb. Vasc. Biol. 24, 1150-1160 (2004). (Pubitemid 38880002)
22. Ghosh S, St. Clair R, Rudel L: Mobilization of cytoplasmic CE droplets by overexpression of human macrophage cholesteryl ester hydrolase. J. Lipid Res. 44, 1883-1840 (2003).
23. Barter PJ, Rye KA: Molecular mechanisms of reverse cholesterol transport. Curr. Opin. Lipidol. 7(2), 82-87 (1996). (Pubitemid 26167021)
24. Yancey P, Bortnick A, Kellner-Weibel G, De la Liera-Moya M, Phillips M, Rothblat G: Importance of different pathways of cellular cholesterol efflux. Arterioscler. Thromb. Vasc. Biol. 23, 712-719 (2003). (Pubitemid 36566157)
25. De Duve C: The participation of lysosomes in the transformation of smooth muscle cells to foamy cells in the aorta of cholesterol fed rabbits. Acta Cardiol. Suppl. 20, 9-25 (1974).
26. Hers HG: The concept of inborn lysosomal disease. In: Lysosomes and Storage Diseases. Hers H, van Hooff F (Eds). Academic Press, NY, USA 141-171 (1973).
27. Vellodi A: Lysosomal storage disorders. Br. J. Haemotol. 128, 413-431 (2004).
28. Jerome WG, Lewis JC: Early atherogenesis in White Carneau pigeons II ultrastructural and cytochemical observations. Am. J. Pathol. 119, 210-222 (1985). (Pubitemid 15040420)
29. Fowler S, Berberian P, Shio H, Goldfischer S, Wolinsky H: Characterization of cell populations isolated from aortas of rhesus monkeys with experimental atherosclerosis. Circ. Res. 46, 520-530 (1980).
30. Miller B, Kothari H: Increased activity of lysosomal enzymes in human atherosclerotic aortas. Exp. Mol. Pathol. 10, 288-294 (1969).
31. Tardif J, Gregoire J, L'Allier P et al.: Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions. Circulation 110, 3372-3377 (2004). (Pubitemid 39557502)
32. Nissen S, Tuzcu E, Brewer H et al.: Effect of ACAT inhibition on the progression of coronary atherosclerosis. N. Engl. J. Med. 354, 1253-1263 (2006).
33. Jerome WG, Lewis JC: Cellular dynamics in early atherosclerotic lesion progression in White Carneau pigeons. Spatial and temporal analysis of monocyte and smooth muscle invasion of the intima. Arterioscler. Thromb. Vasc. Biol. 17, 654-664 (1997). (Pubitemid 27169125)
34. Jerome WG, Lewis JC: Early atherogenesis in White Carneau pigeons. Effect of a short-term regression diet. Exp. Mol. Pathol. 53, 223-238 (1990).
35. Yancey PG, Jerome WG: Lysosomal cholesterol derived from mildly oxidized low density lipoprotein is resistant to efflux. J. Lipid Res. 42, 317-327 (2001). (Pubitemid 32270054)
36. Du H, Schiavi S, Wan N, Levine M, Witte D, Grabowski G: Reduction of atherosclerotic plaques by lysosomal acid lipase supplementation. Arterioscl. Thromb. Vasc. Biol. 24, 147-154 (2004). (Pubitemid 38082426)
37. Lingwood D, Simons K: Lipid rafts as a membrane organizing principal. Science 327, 46-50 (2010).
38. Smart EJ, Anderson RG: Alterations in membrane cholesterol that affect structure and function of caveolae. Methods Enzymol. 353, 131-139 (2002). (Pubitemid 34625587)
39. Bagnat M, Keranen S, Shevchenko A, Shevchenko A, Simons K: Lipid rafts function in biosynthetic delivery of proteins to the cell surface of yeast. Proc. Natl Acad. Sci. USA 97, 3254-3259 (2000). (Pubitemid 30183288)
40. Schroeder F, Gallegos A, Atshves BP et al.: Recent advances in membrane microdomains: rafts, caveolae, and intracellular cholesterol traficking. Exp. Biol. Med. 226, 873-890 (2001).
41. Liscum L: Niemann-Pick type C mutations cause lipid traffic jam. Traffic 1, 218-225 (2000).
42. Mukherjee S, Maxfield FR: Role of membrane organization and membrane domains in endocytic lipid trafficking. Traffic 1, 203-211 (2000).
43. Maxfield FR, Tabas I: Role of cholesterol and lipid organization in disease. Nature 438, 612-621 (2005). (Pubitemid 41740565)
44. Pichler H, Riezman H: Where sterols are required for endocytosis. Biochim. Biophys. Acta 1666, 51-61 (2004). (Pubitemid 39425198)
45. Qin C, Nagao T, Grosheva I, Maxfield FR, Pierini L: Elevated plasma membrane cholesterol content alters macrophage signaling function. Arterioscler. Thromb. Vasc. Biol. 26, (2006).
46. Cox B, Griffin E, Ullery J, Jerome W: Effects of cellular cholesterol loading on macrophage foam cell lysosome acidification. J. Lipid Res. 48, 1012-1021 (2007). (Pubitemid 46708668)
47. Sando G, Rosenbaum L: Human lysosomal acid lipase/cholesterol ester hydrolase. J. Biol. Chem. 260, 15186-15193 (1985). (Pubitemid 16148010)
48. Zhang G-J, Liu H-W, Yang L, Zhong Y-G, Zheng Y-Z: Influence of membrane physical state on the lysosomal proton permeability. J. Membrane Biol. 175, 53-62 (2000). (Pubitemid 30324332)
49. Grabe M, Oster G: Regulation of organelle acidity. J. Gen. Physiol. 117, 329-343 (2001). (Pubitemid 32428669)
50. Yuan X, Li W, Olsson A, Brunk U: The toxicity to macrophages of oxidized LDL is mediated through lysosomal damage. Atherosclerosis 133, 153-161 (1997). (Pubitemid 27373492)
51. Tabas I, Seimon T, Timmins J, Li G, Lim W: Macrophage apoptosis in advanced atherosclerosis. Ann. NY Acad. Sci. 1173(Suppl. 1), E40-E45 (2009).
52. Liscum L, Sturley S: Intracellular trafficking of Niemann-Pick C proteins 1 and 2: obligate components of subcellular lipid transport. Biochim. Biophys. Acta 1685, 22-27 (2004). (Pubitemid 39328089)
53. Assmann G, Seedorf U: Acid lipase deficiency: Wolman disease and cholesteryl ester storage disease. In: The Metabolic and Molecular Bases of Inherited Disease. Scriver C, Beaudet A, Sly W, Valle D (Eds). McGraw Hill Inc., NY, USA (1995).
54. Kruth HS, Ifrim I, Chang J, Addadi L, Peri-Treves D, Zhang W-Y: Monoclonal antibody detection of plasma membrane cholesterol microdomains responsive to cholesterol trafficking. J. Lipid Res. 42, 1492-1500 (2001). (Pubitemid 34007681)
55. Ridgway N: Interactions between metabolism and intracellular distribution of cholesterol and sphingomyelin. Biochim. Biophys. Acta 1484, 129-141 (2000). (Pubitemid 30175963)
56. Witting S, Maiorano J, Davidson W: Ceramide enhances cholesterol efflux to apolipoprotein A-I by increasing the cell surface presence of ATP-binding cassette transporter A1. J. Biol. Chem. 278, 40121-40127 (2003). (Pubitemid 37248579)
57. Gomez-Munoz A, Kong J, Sahl B, Steinbrecher U: Ceramide-1-phosphate blocks apoptosis through inhibition of acid sphingomyelinase in macrophages. J. Lipid Res. 45, 99-105 (2004). (Pubitemid 38176619)
58. Mathias S, Pena L, Kolesnick R: Signal transduction of stress via ceramide. Biochem. J. 335, 465-480 (1998). (Pubitemid 28515396)
59. Feng B, Yao P, Li Y et al.: The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat. Cell Biol. 5, 781-792 (2003). (Pubitemid 37087166)
60. Kellner-Weibel G, Jerome W, Small D et al.: Effects of intracellular free cholesterol accumulation on macrophage viability: a model for foam cell death. Arterioscler. Thromb. Vasc. Biol. 18, 423-431 (1998). (Pubitemid 28125637)
61. Bjorkhem I, Andersson O, Diczfalusy U et al.: Atherosclerosis and sterol 27-hydroxylase: evidence for a role this enzyme in elimination of cholesterol from macrophages. Proc. Natl Acad. Sci. USA 91, 8592-8596 (1994). (Pubitemid 24273710)
62. Fu X, Menke J, Chen Y et al.: 27-Hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded macrophages. J. Biol. Chem. 276, 38378-38387 (2001).
63. Szanto A, Benko S, Szatmari I et al.: Transcriptional regulation of human CYP27 integrates retinoid, peroxisome proliferation-activated receptor, and liver X receptor signaling in macrophages. Molec. Biol. Cell 24, 8154-8166 (2004). (Pubitemid 39167464)
64. Lund-Katz S, Phillips MC: High density lipoprotein structure-function and role in reverse cholesterol transport. Subcell. Biochem. 51, 183-227 (2010).
65. Ooi T, Ooi D: The atherogenic significance of an elevated plasma triglyceride level. Critical Rev. Clin. Lab. Sci. 35, 489-516 (1998). (Pubitemid 29034228)
66. Rapp J, Lespine A, Hamilton R et al.: Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler. Thromb. 14, 1767-1774 (1994).
67. Mattsson H, Johansson H, Ottosson M, Bondjers G, Wiklund O: Expression of lipoprotein lipase mRNA and secretion in macrophages isolated from human atherosclerotic aorta. JCI 92(4), 1759-1765 (1993). (Pubitemid 23304540)
68. Mukhin D, Orekhov A, Andreeva E, Schindeler E, Smirnov V: Lipids in cells of atherosclerotic and uninvolved human aorta. III. Lipid distribution in intimal sublayers. Exp. Mol. Pathol. 54(1), 22-30 (1991).
69. Garner B, Baoutina A, Dean R, Jessup W: Regulation of serum-induced lipid accumulation in human monocyte-derived macrophages by interferon-gamma. Correlations with apolipoprotein E production, lipoprotein lipase activity and LDL receptor-related protein expression. Atherosclerosis 128(1), 47-58 (1997). (Pubitemid 27065260)
70. Kritharides L, Christian A, Stoudt G, Morel D, Rothblat G: Cholesterol metabolism and efflux in human THP-1 macrophages. Arterioscl. Thromb. Vasc. Biol. 18, 1589-1599 (1998). (Pubitemid 28465411)
71. Mahlberg F, Glick JM, Jerome WG, Rothblat GH: Metabolism of cholesteryl ester lipid droplets in a J774 macrophage foam cell model. Biochim. Biophys. Acta 1045, 291-298 (1990). (Pubitemid 20249374)
72. Snow J, Glick J, Phillips M: The phase behavior of cholesteryl esters in intracellular inclusions. J. Biol. Chem. 267(26), 18564-18572 (1992).
73. Adelman SJ, Glick JM, Phillips MC, Rothblat GH: Lipid composition and physical state effects on cellular cholesteryl ester clearance. J. Biol. Chem. 259, 13844-13850 (1984). (Pubitemid 15222814)
74. Zhao B, Fisher B, St Clair R, Rudel L, Ghosh S: Redistribution of macrophage cholesteryl ester hydrolase from cytoplasm to lipid droplets upon lipid loading. J. Lipid Res. 46, 2114-2121 (2005). (Pubitemid 41377463)
75. Chawla A, Boisvert WA, Lee C-H et al.: A PPARg-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol. Cell 7(1), 161-171 (2001). (Pubitemid 32162909)
76. Zelcer N, Tontonoz P: Liver X receptors as integrators of metabolic and inflammatory signaling. J. Clin. Invest. 116, 607-614 (2006). (Pubitemid 43326865)
77. Saha P, Modarai B, Humphries J et al.: The monocyte/macrophage as a therapeutic target in atherosclerosis. Curr. Opin. Pharmacol. 9(2), 109-118 (2009).
78. Libby P, Okamoto Y, Rocha VZ, Folco E: Inflammation in atherosclerosis: transition from theory to practice. Circ. J. 74(2), 213-220 (2010).
79. Miller Y, Choi S, Fang L, Harkewicz R: Toll-like receptor-4 and lipoprotein accumulation in macrophages. Trends Cardiovasc. Med. 19(7), 227-232 (2009).
80. Ullery-Ricewick J, Cox B, Griffin E, Jerome W: Triglyceride alters lysosomal cholesteryl ester metabolism in cholesteryl-ester laden macrophage foam cells. J. Lipid Res. 50, 2014-2026 (2009).
81. Skarlatos SI, Dichek HL, Fojo SS, Brewer HB, Kruth HS: Absence of triglyceride c-deficient human monocyte-macrophages incubated with human very low density lipoprotein. J. Clin. Endocrinol. Metab. 76(3), 793-796 (1993). (Pubitemid 23086507)
82. Brown R, Rader D: Lipases as modulators of atherosclerosis in murine models. Curr. Drug Targets 8(12), 1307-1319 (2007).
83. Olivecrona G, Olivecrona T: Triglyceride lipases and atherosclerosis. Curr. Opin. Lipidol. 21(5), 409-415 (2010).
84. Ruiz-Gutierrez V, Morgado N, Prada JL, Perez-Jimenez F, Muriana F: Composition of human VLDL triacylglycerols after ingestion of olive oil and high oleic sunflower oil. J. Nutr. 128(3), 570-576 (1998). (Pubitemid 28188354)
85. Jaureguiberry M, Tricerri M, Sanchez S et al.: Membrane organization and regulation of cellular cholesterol homeostasis. J. Membr. Biol. 234(3), 183-194 (2010).
86. Leekumjorn S, Cho H, Wu Y, Wright N, Sum A, Chan C: The role of fatty acid unsaturation in minimizing biophysical changes on the structure and local effects of bilayer membranes. Biochim. Biophys. Acta 1788(7), 1508-1516 (2009).
87. Singh R, Kaushik S, Wang Y et al.: Autophagy regulates lipid metabolism. Nature 458, 1131-1137 (2009).
88. Gianturco S, Bradley W: Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: cellular aspects. Clin. Cardiol. 22(Suppl. 6), II7-II14 (1999). (Pubitemid 29265094)
89. Gianturco S, Ramprasad M, Lin A, Song R, Bradley W: Cellular binding site and membrane binding proteins for triglyceride-rich lipoproteins in human monocyte-macrophages and THP-1 monocytic cells. J. Lipid Res. 35(9), 1674-1687 (1994). (Pubitemid 24291228)
90. Jones N, Allen NS, Lewis JC: b-VLDL uptake by pigeon monocyte-derived macrophages: correlation of binding dynamics with three-dimensional ultrastructure. Cell Motil. Cytoskel. 19, 139-151 (1991).
91. Tabas I, Lim S, Xu XX, Maxfield FR: Endocytosed b-VLDL and LDL are delivered to different intracellular vesicles in mouse peritoneal macrophages. J. Cell Biol. 111, 929-940 (1990).
92. Glick JM, Adelman SJ, Phillips MC, Rothblat GH: Cellular cholesteryl ester clearance. Relationship to the physical state of cholesteryl ester inclusions. J. Biol. Chem. 258, 13425-13430 (1983). (Pubitemid 14204540)
93. Minor LK, Mahlberg FH, Jerome WG, Lewis JC, Rothblat GH, Glick JM: Lysosomal hydrolysis of lipids in a cell culture model of smooth muscle foam cells. Exp. Mol. Pathol. 54, 159-171 (1991).
94. Lada AT, Willingham MC, St Clair R: Triglyceride depletion in THP-1 cells alters cholesteryl ester physical state and cholesterol efflux. J. Lipid Res. 43, 618-628 (2002). (Pubitemid 34252337)
95. Minor LK, Rothblat GH, Glick JM: Triglyceride and cholesteryl ester hydrolysis in a cell culture model of smooth muscle foam cells. J. Lipid Res. 30, 189-197 (1989). (Pubitemid 19067224)
96. Hokanson J, Austin M: Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J. Cardiovasc. Risk 3(2), 213-219 (1996). (Pubitemid 26266496)
97. Williams KJ, Feig JE, Fisher EA: Cellular and molecular mechanisms for rapid regression of atherosclerosis: from bench top to potentially achievable clinical goal. Curr. Opin. Lipidol. 18(4), 443-450 (2007). (Pubitemid 47051924)
98. Tabas I: Apoptosis and plaque destabilization in atherosclerosis: the role of macrophage apoptosis induced by cholesterol. Cell Death Differ. 11, S12-S16 (2004). (Pubitemid 39136793)
99. Li Y, Ge M, Ciani L et al.: Enrichment of endoplasmic reticulum with cholesterol inhibits sarcoplasmic-endoplasmic reticulum calcium ATPase-2b activity in parallel with increased order of membrane lipids. J. Biol. Chem. 279, 37030-37039 (2004).
100. Seimon T, Tabas I: Mechanisms and consequences of macrophage apoptosis in atherosclerosis. J. Lipid Res. 50(Suppl.), S382-S387 (2009).
101. Thim T, Hagensen M, Bentzon J, Falk E: From vulnerable plaque to atherothrombosis. J. Intern. Med. 263(5), 506-516 (2008). (Pubitemid 351545740)
102. Crisby M, Kallin B, Thyberg J et al.: Cell death in human atherosclerotic plaques involves both oncosis and apoptosis. Atherosclerosis 130(1-2), 17-27 (1997). (Pubitemid 27158025)
103. Debnath J, Baehrecke E, Kroemer G: Does autophagy contribute to cell death? Autophagy 1(2), 66-74 (2005).
104. Stary H, Chandler A, Dinsmore R et al.: A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler. Thromb. Vasc. Biol. 15(9), 1512-1531 (1995).
105. Thorp E, Tabas I: Mechanisms and consequences of efferocytosis in advanced atherosclerosis. J. Leukoc. Biol. 86(5), 1089-1095 (2009).
106. Cui D, Thorp E, Li Y et al.: Pivotal advance: macrophages become resistant to cholesterol-induced death after phagocytosis of apoptotic cells. J. Leukoc. Biol. 82(5), 1040-1050 (2007). (Pubitemid 350133499)
107. Martinet W, De Bie M, Schrijvers D, De Meyer G, Herman A, Kockx M: 7-ketocholesterol induces protein ubiquitination, myelin figure formation, and light chain 3 processing in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 24(12), 2296-2301 (2004). (Pubitemid 39658032)
108. Kockx M, De Meyer G, Muhring J, Jacob W, Bult H, Herman A: Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation 97(23), 2307-2315 (1998). (Pubitemid 28280384)
109. Xu K, Yang Y, Yan M, Zhan J, Fu X, Zheng X: Autophagy plays a protective role in free cholesterol overload-induced death of smooth muscle cells. J. Lipid Res. 51(9), 2581-2590 (2010).
110. Martinet W, De Meyer G: Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potential. Circ. Res. 104(3), 304-317 (2009).
111. Zhang Y, Cao Y, Zhang X et al.: The autophagy-lysosome pathway: a novel mechanism involved in the processing of oxidized LDL in human vascular endothelial cells. Biochem. Biophys. Res. Commun. 394(2), 377-382 (2010).